ClinicalTrialsFinder

Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation Clinical Trials in Chūōku

1 recruitingChūōku, Japan

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation

Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation
Institut de Recherches Internationales Servier52 enrolled37 locationsNCT06501625